Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature

Myasthenia gravis (MG) is one of the most common neuromuscular adverse effects of immune checkpoint inhibitors (ICIs) and can result in significant morbidity and mortality when it affects the bulbar and respiratory muscles. Diagnosing immune-related MG (irMG) is challenging due to its nonspecific pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Eglenen Polat, Buse, Safi, Danish, Hafez, Maria, Kamran, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378713/
https://www.ncbi.nlm.nih.gov/pubmed/37519591
http://dx.doi.org/10.7759/cureus.41087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378713/
https://www.ncbi.nlm.nih.gov/pubmed/37519591
http://dx.doi.org/10.7759/cureus.41087

Ejemplares similares